Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Purpose Canadian Financial Income Series A T.BNC

The fund seeks to provide shareholders with (i) long-term capital appreciation through investment in a portfolio of Canadian Banks (defined below) (up to 70% on an equal weighted basis) and Canadian Insurance Companies (defined below) (up to 30% on an equal weighted basis) and (ii) monthly distributions.To achieve its investment objectives, the fund will invest primarily in equity securities of Canadian Banks (up to 70% on an equal weighted basis) and to a lesser extent Canadian Insurance Companies (up to 30% on an equal weighted basis). portfolio of Canadian Banks (defined below) (up to 70% on an equal weighted basis) and CanadianInsurance Companies (defined below) (up to 30% on an equal weighted basis) and (ii) monthlydistributions.


TSX:BNC - Post by User

Comment by LittleLadyPhDon Aug 30, 2016 2:46pm
229 Views
Post# 25192213

RE:RE:RE:RE:RE:RE:MCNA not officially dead yet

RE:RE:RE:RE:RE:RE:MCNA not officially dead yet
You are confusing human use of MCNA and animal use...my post from Aug 12 is entirely about the animal formultion. It is being used for animal cancers - is owned and distributed by Novavive, a privately held company run by the former owner of Bioniche who developed the MCNA technology over 30 years...TST emerged from the takeover of Bioniche and focused entirely on human bladder cancer application for MCNA.
<< Previous
Bullboard Posts
Next >>